FGF23 and X-linked hypophosphatemia: In contrast, the correction of FGF23 excess, either by reducing its expression or by blocking its signaling, has been shown to improve serum Pi levels, bone growth, and mineralization in patients and animal models with XLH (8, 10, 26, 33).